老年医保受益者入住临终关怀后使用Medicare Part D药物情况
该研究基于SEER-Medicare关联数据库,描述2008至2013年间入住临终关怀并在此去世的66岁及以上Part D参保者(N=88,957)的药物使用情况。结果显示,癌症与非癌原因入住者中分别有53.5%和52.9%在入住后至少配取1种Part D药物,预防性药物常见,入住诊断间存在差异。
要点
- 癌症与非癌入住者中分别有53.5%和52.9%在临终关怀入住后仍通过Part D配药。
- 虚弱或衰竭入住者配药比例最高(63.5%),缺血性卒中(35.4%)和肾病(36.0%)最低。
- β受体阻滞剂、ACEI、PPI、他汀等预防性药物常见,近1/6患者入住后经Part D获阿片类。
核心结论
- 临终关怀入住后通过Medicare Part D配取药物常见,尤其是预防性药物,且随入住诊断不同而变化。
主要发现
- 癌症入住者中53.5%、非癌入住者中52.9%在入住后至少配取1种Part D药物。
- 入住后至少配取1种Part D药物的比例在虚弱或衰竭入住者中最高(63.5%),痴呆入住者次之(61.5%),缺血性卒中(35.4%)和肾病(36.0%)最低。
- β受体阻滞剂、血管紧张素转换酶抑制剂、质子泵抑制剂和他汀是总体最常见的预防性药物类别,但比例随入住诊断不同。
- 近1/6患者在入住后通过Part D获得阿片类药物,该比例在研究期间稳步下降。
临床怎么用
- 老年医学科医生应关注临终关怀患者经Part D继续使用预防性药物的情况,结合入住诊断评估用药适宜性。
局限性
- 研究为描述性分析,未探讨个体、提供者及医疗系统层面因素对非姑息性用药的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To describe medications that older hospice beneficiaries receive through Medicare Part D and assess patterns in Part D use for individuals admitted to hospice for cancer and noncancer causes. DESIGN: Descriptive cohort analysis using the Surveillance, Epidemiology and End Results (SEER)-Medicare linked database. SETTING: U.S. hospice programs PARTICIPANTS: Part D-enrolled Medicare beneficiaries aged 66 and older who were admitted to hospice and died while under hospice care between January 1, 2008, and December 31, 2013 (N = 88,957). MEASUREMENTS: We determined the 25 most commonly dispensed medications and the prevalence of at least 1 dispensing through Part D after hospice admission. The prevalence and temporal trends in receipt of opioid analgesics and several preventative medication classes are described. RESULTS: More than half of individuals admitted to hospice for cancer (53.5%) and noncancer causes (52.9%) received at least 1 medication through Part D after hospice admission. The prevalence of receiving at least 1 Part D medication after admission was greatest in individuals admitted for debility or failure to thrive (63.5%) and dementia (61.5%) and lowest in those admitted for ischemic stroke (35.4%) and renal disease (36.0%). Beta-blockers, angiotensin-converting enzyme inhibitors, proton pump inhibitors, and statins were among the most common preventative drug classes received overall, although prevalence differed according to admission diagnosis. Nearly 1 in 6 individuals received opioids through Part D after admission, with prevalence steadily decreasing over the study period. CONCLUSION: Receipt of medications through Medicare Part D after hospice admission is common, particularly for preventative medications, and varies according to admission diagnosis. Further research aimed at better understanding individual-, provider-, and healthcare system-level contributors to nonpalliative medication use in the hospice population is warranted.
引用
- Zueger PM, Holmes HM, Calip GS, et al. Medicare Part D Use of Older Medicare Beneficiaries Admitted to Hospice. J Am Geriatr Soc. 2018. PMID: 29509282. doi:10.1111/jgs.15328
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。